Suppr超能文献

相似文献

1
Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study.
Chron Respir Dis. 2025 Jan-Dec;22:14799731241312687. doi: 10.1177/14799731241312687.
2
Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
Int J Chron Obstruct Pulmon Dis. 2021 Sep 23;16:2665-2675. doi: 10.2147/COPD.S322041. eCollection 2021.
3
Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia Study.
Int J Chron Obstruct Pulmon Dis. 2023 Nov 30;18:2839-2847. doi: 10.2147/COPD.S425202. eCollection 2023.
4
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6. Epub 2021 Nov 2.
6
Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
Chest. 2022 Mar;161(3):651-661. doi: 10.1016/j.chest.2021.09.021. Epub 2021 Sep 27.
7
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
8
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.
Int J Chron Obstruct Pulmon Dis. 2021 Jun 17;16:1771-1782. doi: 10.2147/COPD.S302259. eCollection 2021.

引用本文的文献

本文引用的文献

1
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995. doi: 10.1164/rccm.202302-0310ST.
2
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry.
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001298.
3
Concerns about PRISm.
Lancet Respir Med. 2022 Jun;10(6):e51-e52. doi: 10.1016/S2213-2600(22)00134-5.
4
The Clinical Spectrum of PRISm.
Am J Respir Crit Care Med. 2022 Sep 1;206(5):524-525. doi: 10.1164/rccm.202205-0965ED.
5
ERS/ATS technical standard on interpretive strategies for routine lung function tests.
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
6
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
7
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6. Epub 2021 Nov 2.
9
Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
Int J Chron Obstruct Pulmon Dis. 2021 Sep 23;16:2665-2675. doi: 10.2147/COPD.S322041. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验